Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUCOVAC_2: Impact of Influenza Vaccination on Nasal Resident Memory Immune Responses
NCT06824779Phase 4Active, not recruiting
- Sponsor
- CHU Saint-Etienne
- Start
- Dec 2025
- Primary completion
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine in influenza, sponsored by CHU Saint-Etienne. Started Dec 2025; status: active, not recruiting.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT06824779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06824779.